These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27590486)

  • 1. Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse model.
    Heim C; Motsch B; Jalilova S; Bernhardt WM; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
    Transpl Immunol; 2016 Nov; 39():66-73. PubMed ID: 27590486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.
    Heim C; Bernhardt W; Jalilova S; Wang Z; Motsch B; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
    Interact Cardiovasc Thorac Surg; 2016 May; 22(5):561-70. PubMed ID: 26819270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel reduces post-transplant obliterative bronchiolitis.
    Preidl RH; Eckl S; Ramsperger-Gleixner M; Koch N; Spriewald BM; Weyand M; Ensminger SM
    Transpl Int; 2013 Oct; 26(10):1038-48. PubMed ID: 23952051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.
    Vogler M; Zieseniss A; Hesse AR; Levent E; Tiburcy M; Heinze E; Burzlaff N; Schley G; Eckardt KU; Willam C; Katschinski DM
    Pflugers Arch; 2015 Oct; 467(10):2141-9. PubMed ID: 25578858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse.
    Ropponen JO; Keränen MA; Raissadati A; Nykänen AI; Krebs R; Lemström KB; Tikkanen JM
    J Heart Lung Transplant; 2016 May; 35(5):671-8. PubMed ID: 26856676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.
    Bernhardt WM; Gottmann U; Doyon F; Buchholz B; Campean V; Schödel J; Reisenbuechler A; Klaus S; Arend M; Flippin L; Willam C; Wiesener MS; Yard B; Warnecke C; Eckardt KU
    Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21276-81. PubMed ID: 19934037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis.
    Schley G; Klanke B; Kalucka J; Schatz V; Daniel C; Mayer M; Goppelt-Struebe M; Herrmann M; Thorsteinsdottir M; Palsson R; Beneke A; Katschinski DM; Burzlaff N; Eckardt KU; Weidemann A; Jantsch J; Willam C
    Kidney Int; 2019 Aug; 96(2):378-396. PubMed ID: 31146971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
    Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
    Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits.
    Zhou J; Li J; Rosenbaum DM; Zhuang J; Poon C; Qin P; Rivera K; Lepore J; Willette RN; Hu E; Barone FC
    PLoS One; 2017; 12(9):e0184049. PubMed ID: 28880966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
    Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
    Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models.
    Schindler K; Bondeva T; Schindler C; Claus RA; Franke S; Wolf G
    Nephrol Dial Transplant; 2016 Jul; 31(7):1100-13. PubMed ID: 26908768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
    Nusair S; Or R; Junadi S; Amir G; Breuer R
    Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cells in a mouse airway model of obliterative bronchiolitis.
    Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase.
    Minamoto K; Harada H; Lama VN; Fedarau MA; Pinsky DJ
    J Exp Med; 2005 Jul; 202(2):283-94. PubMed ID: 16027238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis.
    Visner GA; Lu F; Zhou H; Latham C; Agarwal A; Zander DS
    Transplantation; 2003 Aug; 76(4):650-6. PubMed ID: 12973103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
    Farivar AS; Woolley SM; Naidu BV; Fraga CH; Byrne K; Thomas R; Salzman AL; Szabo CS; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):993-1002. PubMed ID: 15312830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
    Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
    Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.